Recent Regulatory Developments India’s biopharmaceutical industry stands at an inflection point where its scientific capabilities and production scale are increasingly recognized globa...
Key Highlights: Implications: Survey hands GSK potent ammo to ignite shingles vaccination drives targeting CKD/diabetes clinics where patient disruption peaks. Chronic disease n...
Key Highlights: Implications: StopBleed fills critical gap in India’s trauma response, handing emergency teams a game-changing tool that slashes preventable bleeding death...
Key Highlights: Implications: The Ayush Grid and My Ayush portal move traditional medicine closer to mainstream digital health, creating a unified infrastructure that can plug in...
Key Highlights: Implications: CANTAB’s India entry taps the $1B+ digital diagnostics market (25% CAGR), challenging manual screening while accelerating early dementia detection amid ...
Key Highlights: Implications: IIL grabs first-mover advantage in niche viral vaccine space, dominating government tenders and regional immunization drives. Homegrown breakthrough smashes i...
Key Highlights: Implications: Quality failures erode trust in high-volume generics, handing innovator brands a compliance advantage as hospitals pivot to verified suppliers. Tie...
Key Highlights: Implications: Dr. Reddy’s grabs monopoly control over Hepatitis E prevention, dominating public health tenders and private vaccination drives as awareness explo...
